Company Overview - LifeMD is building a leading platform for comprehensive virtual healthcare[7] - The company has conducted 13 million virtual consults and has 297000 active patients[8] - LifeMD's revenue guidance for 2025 is between $250 million and $255 million[8] - The company has over 300 employees across the US[8] Investment Highlights - LifeMD forecasts $27 million to $29 million of Adjusted EBITDA for 2025[12] - The company's products and services generate 85%+ consolidated gross margins[12] - WorkSimpli, in which LifeMD holds a 73% equity stake, provides high-margin recurring revenue[9, 12] Financial Performance and Guidance - LifeMD forecasts 20% revenue growth in 2025, with revenue reaching $255 million[42] - Telehealth revenue is projected to grow by 23% to 27%, reaching $195 million to $200 million in 2025[50] - WorkSimpli is expected to generate $55 million in revenue in 2025, a 2% increase[50] - Consolidated Adjusted EBITDA is projected to increase by 93% to 107%, reaching $27 million to $29 million in 2025[50]

Core Viewpoint - LifeMD, Inc. is set to report its financial results for the second quarter of 2025 on August 5, 2025, after market close, indicating ongoing transparency and engagement with investors [1]. Group 1: Financial Reporting - LifeMD will announce its financial results for the three and six months ended June 30, 2025 [1]. - The conference call to discuss these results will begin at 4:30 p.m. Eastern time on August 5, 2025 [2]. Group 2: Company Overview - LifeMD is a prominent provider of virtual primary care services, offering telemedicine, laboratory access, and pharmacy services across over 200 conditions [3]. - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, and a large affiliated pharmacy to enhance access to affordable healthcare [3].

Core Insights - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine and access to various healthcare services across more than 200 conditions [1][2] - The company will participate in two investor conferences in June, focusing on topics related to consumer and enterprise healthcare solutions [2] Company Overview - LifeMD provides a vertically integrated digital care platform, a 50-state affiliated medical group, and a 22,500-square-foot affiliated pharmacy [1] - The services offered include primary care, men's and women's health, weight management, and hormone therapy [1] Upcoming Events - Management will participate in the BTIG Obesity Health Forum on June 18, discussing "Direct to Consumer vs. Direct to Enterprise" [2] - The company will also be present at the Truist Securities Healthcare Disruptors & Digital Health Conference on June 24-25, with a panel discussion on "Tailored Approach to Weight Loss Solutions" [2]

Company Overview - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine, laboratory and pharmacy access, and specialized treatment for over 200 conditions [3] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, and a 22,500-square-foot affiliated pharmacy to enhance access to high-quality and affordable care [3] Financial Reporting - LifeMD will report its financial results for the three months ended March 31, 2025, after the close of U.S. financial markets on May 6, 2025 [1] - A conference call will be held on the same day at 4:30 p.m. Eastern time to discuss the financial results [2] Contact Information - Investor inquiries can be directed to Marc Benathen, Chief Financial Officer, via email at marc@lifemd.com [4] - Media inquiries can be directed to Jessica Friedeman, Chief Marketing Officer, via email at press@lifemd.com [4]

Core Insights - LifeMD, Inc. has announced the acquisition of key assets from Optimal Human Health MD, marking its entry into the women's health market and establishing a scalable clinical foundation for a comprehensive virtual health program focused on hormone health, bone density, metabolism, and long-term wellness [1][2][3] Company Strategy - The expansion into women's health addresses significant unmet needs in areas such as perimenopause, menopause, and hormonal balance, which have historically been underserved [2][3] - LifeMD aims to leverage its national provider network, partnerships with Quest and Labcorp, in-house mail-order pharmacy, and behavioral health services to create a comprehensive virtual-first women's health offering [3][5] - The acquisition aligns with LifeMD's broader strategy of scaling high-demand specialty care verticals, following the success of its men's health initiative, Rex MD [5] Market Opportunity - The women's health market, particularly in menopause and osteoporosis, represents a projected opportunity of $60–70 billion by 2030, highlighting the urgency for solutions that cater to women's health needs at every life stage [2][4] Team and Expertise - The acquisition brings Optimal's trained team, including nurse practitioners and registered dietitians, as well as Dr. Doug Lucas, a respected leader in osteoporosis reversal and hormone optimization, to LifeMD [4][5] - Dr. Lucas will play a central role in shaping LifeMD's women's health strategy, leveraging his clinical experience and thought leadership [4][5]

Company Overview - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine, laboratory and pharmacy access, and specialized treatment for over 200 conditions [2] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, a 22,500-square-foot affiliated pharmacy, and a U.S.-based patient care center to enhance access to high-quality and affordable care [2] Upcoming Events - Management will participate in the 24th Annual Needham Virtual Healthcare Conference from April 7-10, 2025, presenting a corporate overview and conducting one-on-one meetings with investors [1]